drugset / Trial / NCT07377721

A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain

NCT07377721

Phase 1 Recruiting 168 enrolled Shandong Suncadia Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to investigate the efficacy and safety of HRS-2129 in Chinese diabetic peripheral neuropathic pain (DPNP) in comparison to placebo.

Timeline

Start
2026-03-24
Primary completion
2026-09
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-2129 Unknown
Comparator Pregabalin Small molecule